Amerise Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Jun '25 Jun 18, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	57	60	44	46	90	109	Upgrade
Market Cap Growth	37.88%	37.88%	-5.71%	-48.53%	-17.58%	101.22%	Upgrade
Enterprise Value	57	60	45	46	90	121	Upgrade
Last Close Price	0.86	0.91	0.66	0.70	1.36	1.65	Upgrade
PE Ratio	996.83	1054.79	-	-	16.36	-	Upgrade
PS Ratio	30.22	31.98	121.46	525.55	0.94	-64.52	Upgrade
PB Ratio	1.06	1.12	0.81	0.84	1.59	2.14	Upgrade
P/TBV Ratio	1.06	1.12	0.81	0.84	1.59	2.14	Upgrade
P/OCF Ratio	1.85	1.96	-	-	146.34	-	Upgrade
EV/Sales Ratio	30.10	31.90	124.09	524.95	0.94	-	Upgrade
EV/EBIT Ratio	-	799.52	-	-	16.32	-	Upgrade
Debt / Equity Ratio	-	-	-	0.02	0.02	-	Upgrade
Asset Turnover	0.03	0.03	0.01	0.00	1.09	-	Upgrade
Quick Ratio	0.01	0.01	1.36	0.37	0.99	0.04	Upgrade
Current Ratio	0.01	0.01	1.48	0.37	0.99	0.04	Upgrade
Return on Equity (ROE)	0.11%	0.11%	-2.68%	-2.13%	10.24%	-6.41%	Upgrade
Return on Assets (ROA)	0.07%	0.07%	-1.65%	-1.18%	3.90%	-3.62%	Upgrade
Return on Capital (ROIC)	0.09%	0.09%	-1.66%	-1.83%	6.35%	-4.01%	Upgrade
Return on Capital Employed (ROCE)	0.10%	0.10%	-	-	9.60%	-	Upgrade
Earnings Yield	0.10%	0.10%	-3.35%	-2.57%	6.11%	-3.09%	Upgrade
Buyback Yield / Dilution	19.86%	19.86%	-	-	-	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.